MP11-05 OUTCOMES WITH MINIMALLY INVASIVE RETROPERITONEAL LYMPH NODE DISSECTION (MI-RPLND) AND SINGLE DOSE CARBOPLATIN IN CLINICAL STAGE 2 SEMINOMA
Sign Up to like & getrecommendations! Published in 2020 at "Journal of Urology"
DOI: 10.1097/ju.0000000000000831.05
Abstract: INTRODUCTION AND OBJECTIVE:Standard treatment of stage 2 seminoma is usually chemotherapy with 3 cycles of bleomycin, etoposide and cis-platinum(BEP) or 4 cycles of EP. Previous reports with limite... read more here.
Keywords: stage seminoma; minimally invasive; mp11 outcomes; stage ... See more keywords
Imaging Modality and Frequency in Surveillance of Stage I Seminoma Testicular Cancer: Results From a Randomized, Phase III, Noninferiority Trial (TRISST)
Sign Up to like & getrecommendations! Published in 2022 at "Journal of Clinical Oncology"
DOI: 10.1200/jco.21.01199
Abstract: PURPOSE Survival in stage I seminoma is almost 100%. Computed tomography (CT) surveillance is an international standard of care, avoiding adjuvant therapy. In this young population, minimizing irradiation is vital. The Trial of Imaging and… read more here.
Keywords: noninferiority; stage seminoma; surveillance; trial ... See more keywords